Reduced expression of endothelial and inducible nitric oxide synthase in a multidrug resistant variant of the MCF-7 human breast cancer cell line

Oncology Reports

Volumn 12, Issue 5, 2004, Pages 1007-1011

  Lahiri, M ^a   Martin, J H J ^b  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

Breast cancer; Multi drug resistance; Nitric oxide

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOS2A PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN;

ARTICLE; BREAST TUMOR; CELL CULTURE; DRUG RESISTANCE; ENZYMOLOGY; FEMALE; HUMAN; METABOLISM; MULTIDRUG RESISTANCE; PATHOLOGY; SECRETION;

ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; TUMOR CELLS, CULTURED;

EID: 16544394235     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.5.1007     Document Type: Article

References (41)

1. Bredt DS and Snyder SH: Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63: 175-195, 1994.
2. Moncada S, Palmer RM and Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
3. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064, 1992.
4. Stuehr DJ, Kwon NS, Nathan CF, Griffith OW, Feldman PL and Wiseman JN: omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem 266: 6259-6263, 1991. (Pubitemid 21906212)
5. Knowles RG and Moncada S: Nitric oxide synthases in mammals. Biochem J 298: 249-258, 1994. (Pubitemid 24072462)
6. Morris SM Jr and Billiar TR: New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 266: E829-E839, 1994.
7. Bogdan C: Nitric oxide and the regulation of gene expression Trends Cell Biol 11: 66-75, 2001.
8. Aoki E, Takeuchi IK and Shoji R: Nitric oxide: an attractive signaling molecule. Acta Histochem Cytochem 28: 97-106, 1995.
9. Curley SA, Roh MS, Feig B, Oyedeji C, Kleinerman ES and Klostergaard J: Mechanisms of Kupffer cell cytotoxicity in vitro against the syngeneic murine colon adenocarcinoma line MCA26. J Leukoc Biol 53: 715-721, 1993. (Pubitemid 23234843)
10. Jiang H, Stewart CA, Fast DJ and Leu RW: Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target. J Immunol 149: 2137-2146, 1992.
11. Kurose I, Miura S, Fukumura D, Yonei Y, Saito H, Tada S, Suematsu M and Tsuchiya M: Nitric oxide mediates Kupffer cellinduced reduction of mitochondrial energization in hepatoma cells: a comparison with oxidative burst. Cancer Res 53: 2676-2682, 1993. (Pubitemid 23168039)
12. Leu RW, Leu NR, Shannon BJ and Fast DJ: IFN-gamma differentially modulates the susceptibility of L12I0 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production. J Immunol 147: 1816-1822, 1991.
13. Yim CY, McGregor JR, Kwon OD, Bastian NR, Rees M, Mori M, Hibbs JB Jr and Samlowski WE: Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor. J Immunol 155: 4382-4390, 1995.
14. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG and Moncada S: Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41-44, 1995.
15. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC and Moncada S: Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92: 4392-4396, 1995.
16. Dong Z, Staroselsky AH, Qi X, Xie K and Fidler IJ: Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res 54: 789-793, 1994. (Pubitemid 24068338)
17. Xie K, Huang S, Dong Z, Juang SH, Gutman M, Xie QW, Nathan C and Fidler IJ: Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 181: 1333-1343, 1995.
18. Lala PK and Orucevic A: Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Rev 17:91-106, 1998. (Pubitemid 28194648)
19. Thomsen LL and Miles DW: Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev 17: 107-118, 1998. (Pubitemid 28194649)
20. Ambs S, Bennett WP, Merriam WG, Ogunfusika MO, Oser SM, Harrington AM, Shields PG, Felley-Bosco E, Hussain SP and Harris CC: Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J Natl Cancer Inst 91: 86-88, 1999. (Pubitemid 29042448)
21. Gallo O, Sardi I, Masini M and Franchi A: Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J Natl Cancer Inst 91: 1509-1511, 1999. (Pubitemid 29424559)
22. Alalami O and Martin JH: ZR-75-1 human breast cancer cells: expression of inducible nitric oxide synthase and effect of tamoxifen and phorbol ester on nitric oxide production. Cancer Lett 123: 99-105, 1998. (Pubitemid 28046216)
23. Martin JH, Alalami O and van den Berg HW: Reduced expression of endothelial and inducible nitric oxide synthase in a human breast cancer cell line which has acquired estrogen independence. Cancer Lett 144: 65-74, 1999. (Pubitemid 29392899)
24. Martin JHJ, Begum S, Alalami O, Harrison A and Scott K: Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer. Tumor Biol 21: 90-97, 2000. (Pubitemid 30114654)
25. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS and Tannenbaum SR: Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126: 131-138, 1982. (Pubitemid 13203451)
26. Jenkins DC, Charles IG, Baylis SA, Leichuk R, Radomski MW and Moncada S: Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer 70: 847-849, 1994. (Pubitemid 24331075)
27. 2+/calmodulin-dependent nitric oxide synthase activity in the human cervix carcinoma cell line ME-180. Biochem J 289: 357-361, 1993.
28. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros- Moreno V and Moncada S: Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54: 1352-1354, 1994. (Pubitemid 24108080)
29. Martin JH and Edwards SW: Changes in mechanisms of monocyte/macrophage- mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J Immunol 150: 3478-3486, 1993. (Pubitemid 23129728)
30. Kolb JP, Paul-Eugene N, Damais C, Yamaoka K, Drapier JC and Dugas B: Interleukin-4 stimulates cGMP production by IFN-gamma-activated human monocytes. Involvement of the nitric oxide synthase pathway. J Biol Chem 269: 9811-9816, 1994.
31. Zembala M, Siedlar M, Marcinkiewicz J and Pryjma J: Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur J Immunol 24: 435-439, 1994. (Pubitemid 24041136)
32. Mantovani A, Bottazzi B, Colotta F, Sozzani S and Ruco L: The origin and function of tumor-associated macrophages. Immunol Today 13: 265-270, 1992
33. MacRitchie AN, Jun SS, Chen Z, German Z, Yuhanna IS, Sherman TS and Shaul PW: Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res 81: 355-362, 1997. (Pubitemid 27362522)
34. Kauser K and Rubanyi GM: Potential cellular signalling mechanisms mediating upregulation of endothelial nitric oxide production by estrogen. J Vasc Res 34: 229-236, 1997. (Pubitemid 27281698)
35. Bolander FF Jr: The mechanisms by which nitric oxide affects mammary epithelial growth and differentiation. Biochem Biophys Res Commun 304: 425-430, 2003.
36. Vakkala M, Paakko P and Soini Y: eNOS expression is associated with the estrogen and progesterone receptor status in invasive breast carcinoma. Int J Oncol 17: 667-671, 2000.
37. Simeone AM, Ekmekcioglu S, Broemeling LD, Grimm EA and Tari AM: A novel mechanism by which N-(4-hydroxyphenyl) retinamide inhibits breast cancer cell growth: the production of nitric oxide. Mol Cancer Ther 1: 1009-1017, 2002.
38. Pervin S, Singh R, Gau CL, Edamatsu H, Tamanoi F and Chaudhuri G: Potentiation of nitric oxide-induced apoptosis of MDA-MB-468 cells by farnesyltransferase inhibitor: implications in breast cancer. Cancer Res 61: 4701-4706, 2001. (Pubitemid 32691879)
39. Moon BK, Lee YJ, Battle P, Jessup JM, Raz A and Kim HR: Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: implication of galectin-3 function during metastasis. Am J Pathol 159: 1055-1060, 2001. (Pubitemid 32847195)
40. Niedbala W, Wei XQ, Campbell C, Thomson D, Komai-Koma M and Liew FY: Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression viacGMP. Proc Natl Acad Sci USA 99: 16186-16191 2002. (Pubitemid 35462770)
41. Zeillinger R, Tantscher E, Schneeberger C, Tschugguel W, Eder S, Sliutz G and Huber JC: Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines. Breast Cancer Res Tr 40: 205-207, 1996.